Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pivanex

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Histone deacetylase inhibitory prodrugs that are metabolized to butyric acid and formaldehyde possess antineoplastic properties… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
Chronic myelogenous leukemia (CML) is associated with the high TK activity chimeric protein BCR-ABL, known to contribute to cell… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
This multicenter phase II trial evaluated the therapeutic activity and safety profile of pivaloyloxymethyl butyrate (Pivanex, AN… Expand
Is this relevant?
2004
2004
7279 Background: Pivanex is a histone deacetylase inhibitor that induces tumor cell differentiation and/or apoptosis. It has been… Expand
Is this relevant?
2004
2004
Proc Amer Assoc Cancer Res, Volume 45, 2004 4016 Pivanex™ (pivaloyloxymethyl butyrate) is a histone deacetylase (HDAC… Expand
Is this relevant?
2004
2004
  • 2004
  • Corpus ID: 195151591
 
Is this relevant?
2004
2004
  • 2004
  • Corpus ID: 195112292
 
Is this relevant?